Antibiotics from a molecular production line
|Organization:||IP Bewertungs AG (IPB), 20354, DE|
|I.P. Brief:||Chemo-enzymatic method for synthesis of cyclic peptides for pharmacological relevant molecules e.g. with antibiotic, immunosupressive or cytostatic effects. Based on the natural system of so called non-ribosomal peptide synthetases (NRPS) no longer artifical cofactors like N-acetylcyteamine, SNAC are necessary for cyclization from linear to cyclic molecules. |
|Primary Industry:||Pharma & Biotech|
|Specific Market:||antibiotics, immunosupressiva, cytostatica|
Full IP Descriptions available on-site.